speb/financial-data huggingface dataset:
DuPont ROE decomposition for CNC.V (annual period ending 2024-10-31)
ROE: -1.774982097427958%
Asset turnover: 0
Equity multiplier (leverage): 1.2383139473004463
ROE archetype: Low Return
DuPont ROE decomposition for CNC.V (annual period ending 2025-10-31)
ROE: -12.17070464666981%
Asset turnover: 0
Equity multiplier (leverage): 1.278349038230967
ROE archetype: Low Return
DuPont ROE decomposition for CNDT (annual period ending 2022-12-31)
ROE: -19.84732824427481%
Net margin: -4.717470191809228%
Asset turnover: 1.080369644357323
Equity multiplier (leverage): 3.8942202835332607
EBIT margin: 4.224987039917055%
Interest burden factor: -0.7791411042944786
ROE archetype: Low Return
DuPont ROE decomposition for CNDT (annual period ending 2023-12-31)
ROE: -38.193548387096776%
Net margin: -7.952713594841483%
Asset turnover: 1.1055992870934204
Equity multiplier (leverage): 4.343870967741935
EBIT margin: 2.8210639441160668%
Interest burden factor: -3.1619047619047618
ROE archetype: Low Return
DuPont ROE decomposition for CNDT (annual period ending 2024-12-31)
ROE: 57.72357723577236%
Net margin: 12.693682955899883%
Asset turnover: 1.1650755077243533
Equity multiplier (leverage): 3.9031165311653115
EBIT margin: -1.1620977353992847%
Tax burden factor: 0.8452380952380952
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CNDT (annual period ending 2025-12-31)
ROE: -22.25130890052356%
Net margin: -5.588428665351743%
Asset turnover: 1.2177742193755003
Equity multiplier (leverage): 3.269633507853403
EBIT margin: -1.9066403681788298%
ROE archetype: Low Return
DuPont ROE decomposition for CNNE (quarterly period ending 2025-03-31)
ROE: -6.659987033653563%
Net margin: -109.49612403100775%
Asset turnover: 0.04922724670864339
Equity multiplier (leverage): 1.235574939588613
EBIT margin: -20.73643410852713%
ROE archetype: Low Return
DuPont ROE decomposition for CNNE (quarterly period ending 2025-06-30)
ROE: -15.6415798781686%
Net margin: -216.69691470054445%
Asset turnover: 0.05677193343980218
Equity multiplier (leverage): 1.2714351215038973
EBIT margin: -55.26315789473685%
ROE archetype: Low Return
DuPont ROE decomposition for CNNE (quarterly period ending 2025-09-30)
ROE: -5.387099314798771%
Net margin: -63.98503274087932%
Asset turnover: 0.06478591557831581
Equity multiplier (leverage): 1.2995589509332914
EBIT margin: -12.34798877455566%
ROE archetype: Low Return
DuPont ROE decomposition for CNNE (quarterly period ending 2025-12-31)
ROE: -8.557232241442767%
Net margin: -90.02904162633108%
Asset turnover: 0.07287477954144621
Equity multiplier (leverage): 1.3042878174457122
EBIT margin: -23.330106485963213%
ROE archetype: Low Return
DuPont ROE decomposition for CNNE (quarterly period ending 2026-03-31)
ROE: -3.3554591543406684%
Net margin: -33.36798336798337%
Asset turnover: 0.07514744365894621
Equity multiplier (leverage): 1.338159201379815
EBIT margin: -22.972972972972975%
ROE archetype: Low Return
DuPont ROE decomposition for CNSL.L (annual period ending 2022-03-31)
ROE: -95.91232227488152%
Net margin: -132.7204590701487%
Asset turnover: 0.4787776843285675
Equity multiplier (leverage): 1.5093940419769802
EBIT margin: -6.932896123667875%
ROE archetype: Low Return
DuPont ROE decomposition for CNSL.L (annual period ending 2023-03-31)
ROE: -34.24358516422587%
Net margin: -51.152928703949115%
Asset turnover: 0.4516756812100424
Equity multiplier (leverage): 1.4821153841664274
EBIT margin: -35.97932679565333%
ROE archetype: Low Return
DuPont ROE decomposition for CNSL.L (annual period ending 2024-03-31)
ROE: -3.3836590207027504%
Net margin: -3.3558420298751788%
Asset turnover: 0.6995589396348606
Equity multiplier (leverage): 1.441321190979711
EBIT margin: -5.473705749948844%
ROE archetype: Low Return
DuPont ROE decomposition for CNSL.L (annual period ending 2025-03-31)
ROE: 15.024547234830656%
Net margin: 18.79951980792317%
Asset turnover: 0.6126744959007313
Equity multiplier (leverage): 1.3044421842029357
EBIT margin: -4.741896758703481%
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CNTX (annual period ending 2022-12-31)
ROE: -42.68307376704647%
Asset turnover: 0
Equity multiplier (leverage): 1.0922821573373156
ROE archetype: Low Return
DuPont ROE decomposition for CNTX (annual period ending 2023-12-31)
ROE: -102.78587412667197%
Asset turnover: 0
Equity multiplier (leverage): 1.1586830244773114
ROE archetype: Low Return
DuPont ROE decomposition for CNTX (annual period ending 2024-12-31)
ROE: -49.88945678125379%
Asset turnover: 0
Equity multiplier (leverage): 1.0658240704668986
ROE archetype: Low Return
DuPont ROE decomposition for CNTX (annual period ending 2025-12-31)
ROE: -46.389646271260496%
Asset turnover: 0
Equity multiplier (leverage): 1.069863482525352
ROE archetype: Low Return
DuPont ROE decomposition for CNVI.V (annual period ending 2024-09-30)
Net margin: -2018.2785747339196%
Asset turnover: 0.2524237822684266
EBIT margin: -1213.928736695974%
ROE archetype: Standard Business
DuPont ROE decomposition for CNVI.V (annual period ending 2025-09-30)
Net margin: -224.90681868011401%
Asset turnover: 0.8582318390513014
EBIT margin: -162.81517211137907%
ROE archetype: Standard Business
DuPont ROE decomposition for COALINDIA.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 2.5692269379715973
ROE archetype: Standard Business
DuPont ROE decomposition for COALINDIA.NS (quarterly period ending 2024-12-31)
Net margin: 26.285037414652745%
EBIT margin: 30.296906762821322%
Interest burden factor: 1.2028454359904404
Tax burden factor: 0.7212743440277738
ROE archetype: Standard Business
DuPont ROE decomposition for COALINDIA.NS (quarterly period ending 2025-03-31)
ROE: 9.756450905941719%
Net margin: 22.182197356053784%
Asset turnover: 0.1689540176596802
Equity multiplier (leverage): 2.603267371140709
EBIT margin: 20.93579026767931%
Interest burden factor: 1.4201288612188576
Tax burden factor: 0.7460835289401121
ROE archetype: Standard Business
DuPont ROE decomposition for COALINDIA.NS (quarterly period ending 2025-06-30)
Net margin: 27.42553974334725%
EBIT margin: 32.03902833180104%
Interest burden factor: 1.1463622140984397
Tax burden factor: 0.7467134676727175
ROE archetype: Standard Business
DuPont ROE decomposition for COALINDIA.NS (quarterly period ending 2025-12-31)
Net margin: 23.252451394745375%
EBIT margin: 23.08028023727561%
Interest burden factor: 1.3317470181022701
Tax burden factor: 0.7564947781023392
ROE archetype: Standard Business
DuPont ROE decomposition for COALINDIA.NS (quarterly period ending 2026-03-31)
ROE: 9.01436201955017%
Net margin: 23.4626434958205%
Asset turnover: 0.1627458729210051
Equity multiplier (leverage): 2.3607395158711775
EBIT margin: 20.921711601390665%
Interest burden factor: 1.5038024944198896
Tax burden factor: 0.7457425607192301
ROE archetype: Standard Business
DuPont ROE decomposition for COD.AX (annual period ending 2021-06-30)
ROE: -28.314330344524407%
Equity multiplier (leverage): 1.0528856237156465
ROE archetype: Low Return
DuPont ROE decomposition for COD.AX (annual period ending 2022-06-30)
ROE: -55.734434370921846%
Equity multiplier (leverage): 1.0598272195776821
ROE archetype: Low Return
DuPont ROE decomposition for COD.AX (annual period ending 2023-06-30)
ROE: -31.27316146096287%
Equity multiplier (leverage): 1.0534346189358466
ROE archetype: Low Return
DuPont ROE decomposition for COD.AX (annual period ending 2024-06-30)
ROE: -20.685587819467894%
Equity multiplier (leverage): 1.033967767376224
ROE archetype: Low Return
DuPont ROE decomposition for COF (quarterly period ending 2025-03-31)
ROE: 2.2095621793459443%
Net margin: 14.04%
Asset turnover: 0.020259155112195202
Equity multiplier (leverage): 7.768153347392276
Tax burden factor: 0.8120300751879699
ROE archetype: Low Return
DuPont ROE decomposition for COF (quarterly period ending 2025-06-30)
ROE: -4.902061914749739%
Net margin: -34.00651983779916%
Asset turnover: 0.02182423310647838
Equity multiplier (leverage): 6.605072837511032
ROE archetype: Low Return
DuPont ROE decomposition for COF (quarterly period ending 2025-09-30)
ROE: 2.8402493226379084%
Net margin: 20.641489912053803%
Asset turnover: 0.023415313681771896
Equity multiplier (leverage): 5.876455383082186
Tax burden factor: 0.7284345047923323
ROE archetype: Low Return
DuPont ROE decomposition for COF (quarterly period ending 2025-12-31)
ROE: 1.8766296294667786%
Net margin: 13.86344442278958%
Asset turnover: 0.023131958710212595
Equity multiplier (leverage): 5.85187465098998
Tax burden factor: 1.0166746069556931
ROE archetype: Low Return
DuPont ROE decomposition for COF (quarterly period ending 2026-03-31)
ROE: 1.924941450435414%
Net margin: 14.273521108266035%
Asset turnover: 0.022532498368979092
Equity multiplier (leverage): 5.985177773744117
Tax burden factor: 0.8054835124120044
ROE archetype: Low Return
DuPont ROE decomposition for COFA.PA (quarterly period ending 2024-12-31)
ROE: 2.4311678422571337%
Net margin: 12.738687831394877%
Asset turnover: 0.05183758705632539
Equity multiplier (leverage): 3.6816751799819287
Tax burden factor: 0.6386748660030628
ROE archetype: Low Return
DuPont ROE decomposition for COFA.PA (quarterly period ending 2025-03-31)
ROE: 2.870529436926576%
Net margin: 14.87432818644363%
Asset turnover: 0.05219153738487816
Equity multiplier (leverage): 3.6976393975534436
Tax burden factor: 0.7697953736654805
ROE archetype: Low Return
DuPont ROE decomposition for COFA.PA (quarterly period ending 2025-06-30)
ROE: 2.995421459643521%
Net margin: 14.496507411442497%
Asset turnover: 0.05469825404132576
Equity multiplier (leverage): 3.7776445458488017
Tax burden factor: 0.7374298375184638
ROE archetype: Low Return
DuPont ROE decomposition for COFA.PA (quarterly period ending 2025-12-31)
ROE: 2.0697628017792797%
Net margin: 11.153627221554615%
Asset turnover: 0.05081427990462263
Equity multiplier (leverage): 3.651898317050952
Tax burden factor: 0.7518036335016725
ROE archetype: Low Return
DuPont ROE decomposition for COFA.PA (quarterly period ending 2026-03-31)
ROE: 2.3822762914524667%
Net margin: 13.030033413441778%
Asset turnover: 0.04931336300618153
Equity multiplier (leverage): 3.7075069880513647
Tax burden factor: 0.740980586261893
ROE archetype: Low Return
DuPont ROE decomposition for COHU (annual period ending 2022-12-31)
ROE: 10.426649986380877%
Net margin: 11.91559779766848%
Asset turnover: 0.6621848862730912
Equity multiplier (leverage): 1.3214468353571818
EBIT margin: 15.522377041616684%
Interest burden factor: 1.004383253277532
Tax burden factor: 0.7642899419958173
ROE archetype: Standard Business
DuPont ROE decomposition for COHU (annual period ending 2023-12-31)
ROE: 2.996895707369462%
Net margin: 4.424803794305399%
Asset turnover: 0.5352267632727526
Equity multiplier (leverage): 1.2654348484388862
EBIT margin: 7.180798400809653%
Interest burden factor: 1.0026918784058827
Tax burden factor: 0.6145451370700192
ROE archetype: Low Return
DuPont ROE decomposition for COHU (annual period ending 2024-12-31)
ROE: -7.727243297265559%
Net margin: -17.377214837012385%
Asset turnover: 0.3737884152096483
Equity multiplier (leverage): 1.189648274186649
EBIT margin: -17.82746236114879%
ROE archetype: Low Return
DuPont ROE decomposition for COHU (annual period ending 2025-12-31)
ROE: -9.044281948089111%
Net margin: -16.397398422804866%
Asset turnover: 0.40399269174905245
Equity multiplier (leverage): 1.3652922803407146
EBIT margin: -13.16375100451258%
ROE archetype: Low Return
DuPont ROE decomposition for COLA.TO (quarterly period ending 2025-03-31)
ROE: 12.016285940765295%
Net margin: 29.966753526821822%
Asset turnover: 0.10941248181210429
Equity multiplier (leverage): 3.6649131656698133
EBIT margin: 33.40821277742834%
Interest burden factor: 1.0911780527165142
Tax burden factor: 0.8220359871826473
ROE archetype: Standard Business
DuPont ROE decomposition for COLA.TO (quarterly period ending 2025-06-30)
ROE: 13.422228528942673%
Net margin: 30.39489429597128%
Asset turnover: 0.12424349008382028
Equity multiplier (leverage): 3.554269452660426
EBIT margin: 34.45552453131233%
Interest burden factor: 1.1104422319981477
Tax burden factor: 0.7944120100083403
ROE archetype: Standard Business
DuPont ROE decomposition for COLA.TO (quarterly period ending 2025-09-30)
ROE: 11.569955798533444%
Net margin: 29.674829385788836%
Asset turnover: 0.11755483517790219
Equity multiplier (leverage): 3.316675419979054
EBIT margin: 32.211963067041346%
Interest burden factor: 1.0426221335992025
Tax burden factor: 0.8835763805880946
ROE archetype: Standard Business
DuPont ROE decomposition for COLA.TO (quarterly period ending 2025-12-31)
ROE: 6.906903427705623%
Net margin: 19.590593808154292%
Asset turnover: 0.1129480521564862
Equity multiplier (leverage): 3.121454709839426
EBIT margin: 24.209101674843513%
Interest burden factor: 1.0349406009783368
Tax burden factor: 0.7819041188386227
ROE archetype: Standard Business
DuPont ROE decomposition for COLA.TO (quarterly period ending 2026-03-31)
ROE: 11.249569477906492%
Net margin: 31.799230275817834%
Asset turnover: 0.11846326741498546
Equity multiplier (leverage): 2.986314806450621
EBIT margin: 35.054522129570245%
Interest burden factor: 1.0546660567246111
Tax burden factor: 0.860117111255693
ROE archetype: Standard Business
DuPont ROE decomposition for COLL (quarterly period ending 2025-03-31)
ROE: 1.0309937978279602%
Net margin: 1.3597214174406633%
Asset turnover: 0.10896059061363697
Equity multiplier (leverage): 6.958837028758627
EBIT margin: 11.758186738075011%
Interest burden factor: 0.149370843500311
Tax burden factor: 0.7741832158872518
ROE archetype: Low Return
DuPont ROE decomposition for COLL (quarterly period ending 2025-06-30)
ROE: 5.1358649065660895%
Net margin: 6.373936170212765%
Asset turnover: 0.11662462286977837
Equity multiplier (leverage): 6.9090069432539005
EBIT margin: 18.482446808510637%
Interest burden factor: 0.4899703571531355
Tax burden factor: 0.7038472834067547
ROE archetype: Standard Business
DuPont ROE decomposition for COLL (quarterly period ending 2025-09-30)
ROE: 12.428453652167395%
Net margin: 15.049125672880814%
Asset turnover: 0.13085230154511354
Equity multiplier (leverage): 6.311381934226668
EBIT margin: 29.64640023691136%
Interest burden factor: 0.6998131082039054
Tax burden factor: 0.7253660558062437
ROE archetype: Standard Business
DuPont ROE decomposition for COLL (quarterly period ending 2025-12-31)
ROE: 5.88499574141822%
Net margin: 8.256550287419262%
Asset turnover: 0.12588161984607382
Equity multiplier (leverage): 5.662199926103632
EBIT margin: 29.563541316823155%
Interest burden factor: 0.478053278013764
Tax burden factor: 0.5842058134729301
ROE archetype: Standard Business
DuPont ROE decomposition for COLL (quarterly period ending 2026-03-31)
ROE: 4.721078266137109%
Net margin: 7.490698635799917%
Asset turnover: 0.11697330957035942
Equity multiplier (leverage): 5.388055958586347
EBIT margin: 15.965274906986357%
Interest burden factor: 0.6065510098394614
Tax burden factor: 0.7735325506937033
ROE archetype: Low Return
DuPont ROE decomposition for COLR.BR (annual period ending 2022-03-31)
ROE: 11.697331546241015%
Net margin: 3.1131433018776145%
Asset turnover: 1.6479799059427107
Equity multiplier (leverage): 2.2800048738881444
EBIT margin: 3.7303671995762664%
Interest burden factor: 1.0738916256157636
Tax burden factor: 0.7771181867242309
ROE archetype: Standard Business
DuPont ROE decomposition for COLR.BR (annual period ending 2023-03-31)
ROE: 7.980564447898239%
Net margin: 2.069961820245589%
Asset turnover: 1.6306652337886982
Equity multiplier (leverage): 2.3643211215756375
EBIT margin: 2.6674233825198637%
Interest burden factor: 1.0526112185686654
Tax burden factor: 0.7372289599411981
ROE archetype: Standard Business
DuPont ROE decomposition for COLR.BR (annual period ending 2024-03-31)
ROE: 36.80145678999188%
Net margin: 9.690358512835646%
Asset turnover: 1.696405575148443
Equity multiplier (leverage): 2.238697811236985
EBIT margin: 4.332030097373857%
Interest burden factor: 2.5029799914857382
Tax burden factor: 0.8936984437452166
ROE archetype: Balanced Compounder
DuPont ROE decomposition for COLR.BR (annual period ending 2025-03-31)
ROE: 10.688804660441367%
Net margin: 3.2913096934095742%
Asset turnover: 1.5808729294826738
Equity multiplier (leverage): 2.0542979309776137
EBIT margin: 4.578364981167424%
Interest burden factor: 1.0021312872975277
Tax burden factor: 0.7173543173117822
ROE archetype: Standard Business
DuPont ROE decomposition for COLR.BR (annual period ending 2026-03-31)
ROE: 9.702388527871136%
Net margin: 2.8737154860808842%
Asset turnover: 1.6768189925144783
Equity multiplier (leverage): 2.0134864395087826
EBIT margin: 4.39999243012055%
Interest burden factor: 0.9479569892473119
Tax burden factor: 0.6889745916515426
ROE archetype: Standard Business
DuPont ROE decomposition for CONCORDBIO.NS (annual period ending 2022-03-31)
ROE: 15.856177762791388%
Net margin: 24.69214047766925%
Asset turnover: 0.5396425184434737
Equity multiplier (leverage): 1.1899634072168548
EBIT margin: 33.33055728078595%
Interest burden factor: 1.0058908976948846
Tax burden factor: 0.7364873399068702
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CONCORDBIO.NS (annual period ending 2023-03-31)
ROE: 19.327105834640953%
Net margin: 28.903972179262976%
Asset turnover: 0.5659558279593475
Equity multiplier (leverage): 1.1814810433616898
EBIT margin: 36.688404326246925%
Interest burden factor: 1.0566626534845283
Tax burden factor: 0.7455767368687142
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CONCORDBIO.NS (annual period ending 2024-03-31)
ROE: 21.720986250849702%
Net margin: 30.87029171571612%
Asset turnover: 0.6163741429942018
Equity multiplier (leverage): 1.1415485731121515
EBIT margin: 38.70345921020767%
Interest burden factor: 1.0680390294465685
Tax burden factor: 0.746799171039715
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CONCORDBIO.NS (annual period ending 2025-03-31)
ROE: 21.998975604335534%
Net margin: 31.499973979033037%
Asset turnover: 0.6244390589025283
Equity multiplier (leverage): 1.1184129898103317
EBIT margin: 39.272750419598694%
Interest burden factor: 1.0673499704001472
Tax burden factor: 0.7514706706031483
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CONCORDBIO.NS (annual period ending 2026-03-31)
ROE: 12.997321307386672%
Net margin: 24.934666248581628%
Asset turnover: 0.467256655239518
Equity multiplier (leverage): 1.1155647938416087
EBIT margin: 29.13301860997683%
Interest burden factor: 1.1305998608430705
Tax burden factor: 0.7570231239365938
ROE archetype: Standard Business
DuPont ROE decomposition for COO.V (annual period ending 2022-12-31)
Net margin: -12.368196433850272%
Asset turnover: 1.6868564640368702
EBIT margin: -16.494779312578384%
ROE archetype: Standard Business
DuPont ROE decomposition for COO.V (annual period ending 2023-12-31)
Net margin: -39.60665846725441%
Asset turnover: 1.81864350659371
EBIT margin: -38.022392128564235%
ROE archetype: Standard Business
DuPont ROE decomposition for COO.V (annual period ending 2024-12-31)
Net margin: -132.25243884231625%
Asset turnover: 1.4989013823192594
EBIT margin: -131.1855599395982%
ROE archetype: Standard Business
DuPont ROE decomposition for COO.V (annual period ending 2025-12-31)
Net margin: 6.178851265449893%
Asset turnover: 13.088007122230762
EBIT margin: 3.72691612152469%
Interest burden factor: 1.6578992024435772
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for COOT (annual period ending 2021-06-30)
ROE: 19.939398164566622%
Net margin: 6.4231189057966915%
Asset turnover: 0.8483577491595361
Equity multiplier (leverage): 3.6592076294861577
EBIT margin: 6.069461356541636%
Interest burden factor: 1.058268358340215
Tax burden factor: 1
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for COOT (annual period ending 2022-06-30)
ROE: 42.32433820074779%
Net margin: 8.916480222583246%
Asset turnover: 1.5145732460150754
Equity multiplier (leverage): 3.1340537783709888
EBIT margin: 9.955323266262702%
Interest burden factor: 0.8956494916443385
Tax burden factor: 1
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for COOT (annual period ending 2023-06-30)
ROE: 26.19120993996767%
Net margin: 6.351158692218362%
Asset turnover: 1.387573254648887
Equity multiplier (leverage): 2.9719854380751083
EBIT margin: 8.67251912220396%
Interest burden factor: 0.7759457946818771
Tax burden factor: 0.9437920493051123
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for COOT (annual period ending 2024-06-30)
ROE: -498.99319192805234%
Net margin: -62.94820545848692%
Asset turnover: 1.251521011421123
Equity multiplier (leverage): 6.333927987258176
EBIT margin: 6.757333882998131%
Interest burden factor: -9.178016735839892
ROE archetype: Low Return
DuPont ROE decomposition for COUNCODOS.NS (annual period ending 2022-03-31)
ROE: 11.445597638066257%
Net margin: 11.52681503101058%
Asset turnover: 0.704314924615691
Equity multiplier (leverage): 1.4098154286438804
EBIT margin: 5.613371032469902%
Interest burden factor: 2.420992769518239
Tax burden factor: 0.8481879194630871
ROE archetype: Standard Business
DuPont ROE decomposition for COUNCODOS.NS (annual period ending 2023-03-31)
ROE: 3.440304624516697%
Net margin: 3.816015889795357%
Asset turnover: 0.6308610932419635
Equity multiplier (leverage): 1.4290682831858454
EBIT margin: 5.680886263764914%
Interest burden factor: 0.9099632843791722
Tax burden factor: 0.7381934892251261
ROE archetype: Low Return
DuPont ROE decomposition for COUNCODOS.NS (annual period ending 2024-03-31)
ROE: 6.758067321557515%
Net margin: 6.371451474693866%
Asset turnover: 0.7520124769621774
Equity multiplier (leverage): 1.410454522486468
EBIT margin: 5.912991284912671%
Interest burden factor: 1.3003873380526245
Tax burden factor: 0.8286257189811012
ROE archetype: Standard Business
DuPont ROE decomposition for COUNCODOS.NS (annual period ending 2025-03-31)
ROE: 2.3788941513398716%
Net margin: 3.5763666509047156%
Asset turnover: 0.4659754776394888
Equity multiplier (leverage): 1.427479959646493
EBIT margin: 4.81657279327703%
Interest burden factor: 1.0372809742761278
Tax burden factor: 0.7158260452857313
ROE archetype: Low Return
DuPont ROE decomposition for COUNCODOS.NS (annual period ending 2026-03-31)
ROE: 2.225872641310796%
Net margin: 3.3980610289701723%
Asset turnover: 0.4065628672253833
Equity multiplier (leverage): 1.6111702217045984
EBIT margin: 4.948665884977264%
Interest burden factor: 1.0106333795654185
Tax burden factor: 0.6794373284537969
ROE archetype: Low Return
DuPont ROE decomposition for COUR (quarterly period ending 2025-03-31)
ROE: -1.2776412776412778%
Net margin: -4.350250976017847%
Asset turnover: 0.18849873843566023
Equity multiplier (leverage): 1.5580671580671581
EBIT margin: -8.533184606804237%
ROE archetype: Low Return
DuPont ROE decomposition for COUR (quarterly period ending 2025-06-30)
ROE: -1.2606060606060607%
Net margin: -4.168893639764832%
Asset turnover: 0.1937755683289317
Equity multiplier (leverage): 1.5604848484848486
EBIT margin: -8.070550507749866%
ROE archetype: Low Return
DuPont ROE decomposition for COUR (quarterly period ending 2025-09-30)
ROE: -1.3580734307145677%
Net margin: -4.42842430484037%
Asset turnover: 0.1966383151073309
Equity multiplier (leverage): 1.5595736281089616
EBIT margin: -8.032955715756952%
ROE archetype: Low Return
DuPont ROE decomposition for COUR (quarterly period ending 2025-12-31)
ROE: -4.203262233375157%
Net margin: -13.61097003555104%
Asset turnover: 0.1973638049416128
Equity multiplier (leverage): 1.5646957340025094
EBIT margin: -16.404266124936516%
ROE archetype: Low Return
DuPont ROE decomposition for COUR (quarterly period ending 2026-03-31)
ROE: -3.2347140039447733%
Net margin: -10.475217169136434%
Asset turnover: 0.19565108722819294
Equity multiplier (leverage): 1.5783037475345167
EBIT margin: -12.927950945324476%
ROE archetype: Low Return
DuPont ROE decomposition for COV.PA (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 2.0715391530163805
ROE archetype: Standard Business
DuPont ROE decomposition for COV.PA (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 2.1035797539379417
ROE archetype: Standard Business
DuPont ROE decomposition for COV.PA (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 2.0657488388681298
ROE archetype: Standard Business
DuPont ROE decomposition for COV.V (annual period ending 2022-09-30)
ROE: -39.883232163625706%
Net margin: -53.251434582856426%
Asset turnover: 0.5973514258520807
Equity multiplier (leverage): 1.253802495307127
EBIT margin: -50.38097384658877%
ROE archetype: Low Return
DuPont ROE decomposition for COV.V (annual period ending 2023-09-30)
ROE: -20.9103366925344%
Net margin: -16.773641764935334%
Asset turnover: 0.9700078341284105
Equity multiplier (leverage): 1.2851636118345027
EBIT margin: -17.02745366227684%
ROE archetype: Low Return
DuPont ROE decomposition for COV.V (annual period ending 2024-09-30)
ROE: 11.533220260090062%
Net margin: 8.565664882773433%
Asset turnover: 1.0992801668261794
Equity multiplier (leverage): 1.2248449454802293
EBIT margin: 6.901297115950151%
Interest burden factor: 1.241167383299094
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for COV.V (annual period ending 2025-09-30)
ROE: 6.9710824629346275%
Net margin: 6.271535951274529%
Asset turnover: 0.9529582875922121
Equity multiplier (leverage): 1.1664131646506413
EBIT margin: 5.374370279543911%
Interest burden factor: 1.1669341011253793
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for COVH.PA (annual period ending 2022-12-31)
ROE: 13.34342942784752%
Net margin: 107.61991935708606%
Asset turnover: 0.06632091720281291
Equity multiplier (leverage): 1.869494866593081
EBIT margin: 53.554869121395235%
Interest burden factor: 2.031853150491927
Tax burden factor: 0.9890115951507606
ROE archetype: Standard Business
DuPont ROE decomposition for COVH.PA (annual period ending 2023-12-31)
ROE: -0.32433471562762534%
Net margin: -2.1052631578947367%
Asset turnover: 0.08188209296377835
Equity multiplier (leverage): 1.8814735230482214
EBIT margin: 52.41379310344828%
Interest burden factor: -0.20740997229916897
ROE archetype: Low Return
DuPont ROE decomposition for COVH.PA (annual period ending 2024-12-31)
ROE: 6.407329674751999%
Net margin: 40.42698548249359%
Asset turnover: 0.08173238216973068
Equity multiplier (leverage): 1.9391506701483945
EBIT margin: 49.54739538855679%
Interest burden factor: 0.9210617028610825
Tax burden factor: 0.8858532934131735
ROE archetype: Standard Business
DuPont ROE decomposition for COVH.PA (annual period ending 2025-12-31)
ROE: 9.069650954728873%
Net margin: 45.98015245217891%
Asset turnover: 0.10589140391443534
Equity multiplier (leverage): 1.8627709670222183
EBIT margin: 36.401553286351216%
Interest burden factor: 1.2240221256420387
Tax burden factor: 1.0319561007101357
ROE archetype: Standard Business
DuPont ROE decomposition for COXG.MC (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 4.178134252906767
ROE archetype: Standard Business
DuPont ROE decomposition for COXG.MC (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 4.430849017758292
ROE archetype: Standard Business
DuPont ROE decomposition for COXG.MC (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 4.495192242449098
ROE archetype: Standard Business
DuPont ROE decomposition for CPEN.SW (annual period ending 2022-12-31)
ROE: -16.377140810421047%
Asset turnover: -0.15174000845348237
Equity multiplier (leverage): 1.0035063576296268
ROE archetype: Low Return
DuPont ROE decomposition for CPEN.SW (annual period ending 2023-12-31)
ROE: 4.331992406681573%
Net margin: 781.8352539225314%
Asset turnover: 0.005518961027309607
Equity multiplier (leverage): 1.0039569950887706
Tax burden factor: 0.9353629976580795
ROE archetype: Low Return
DuPont ROE decomposition for CPEN.SW (annual period ending 2024-12-31)
ROE: -3.2576072127646953%
Asset turnover: -0.02359155672377931
Equity multiplier (leverage): 1.0041986899748332
ROE archetype: Low Return
DuPont ROE decomposition for CPEN.SW (annual period ending 2025-12-31)
ROE: 2.7858300597832364%
Net margin: 337.1199493321771%
Asset turnover: 0.008194613220434677
Equity multiplier (leverage): 1.0084205961753892
Tax burden factor: 0.7651416122004358
ROE archetype: Low Return
DuPont ROE decomposition for CPH.TO (annual period ending 2022-12-31)
ROE: 41.566791510611736%
Net margin: 128.83192261185005%
Asset turnover: 0.28024018651051835
Equity multiplier (leverage): 1.151310861423221
EBIT margin: 53.446191051995164%
Interest burden factor: 1.0388235294117647
Tax burden factor: 2.320411185643349
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CPH.TO (annual period ending 2023-12-31)
ROE: 28.5645629307218%
Net margin: 96.31887345241469%
Asset turnover: 0.2684900652317254
Equity multiplier (leverage): 1.1045565832426552
EBIT margin: 48.68159909271335%
Interest burden factor: 1.2309260337798487
Tax burden factor: 1.6073653497358251
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CPH.TO (annual period ending 2024-12-31)
ROE: 12.180004536511001%
Net margin: 34.60420225998861%
Asset turnover: 0.26094174213398064
Equity multiplier (leverage): 1.3488853897970703
EBIT margin: 23.523064472619367%
Interest burden factor: 0.3765290519877676
Tax burden factor: 3.9069373942470387
ROE archetype: Standard Business
DuPont ROE decomposition for CPH.TO (annual period ending 2025-12-31)
ROE: 24.369029468617814%
Net margin: 54.169392083407665%
Asset turnover: 0.3232015192210901
Equity multiplier (leverage): 1.3919091118465452
EBIT margin: 33.428475154109925%
Interest burden factor: 1.0176697302104951
Tax burden factor: 1.5923206898560858
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CPHC (annual period ending 2022-12-31)
ROE: 10.55410755318361%
Net margin: 11.242905810873213%
Asset turnover: 0.724172605803281
Equity multiplier (leverage): 1.2962860611041565
EBIT margin: 16.5178882681178%
Interest burden factor: 0.9272372066627927
Tax burden factor: 0.7340627700970791
ROE archetype: Standard Business
DuPont ROE decomposition for CPHC (annual period ending 2023-12-31)
ROE: 13.809825806547765%
Net margin: 17.193667358444664%
Asset turnover: 0.6238674390176343
Equity multiplier (leverage): 1.2874410746283018
EBIT margin: 8.411958502174704%
Interest burden factor: 2.8986308743948146
Tax burden factor: 0.7051450880422615
ROE archetype: Standard Business
DuPont ROE decomposition for CPHC (annual period ending 2024-12-31)
ROE: 2.547353345192413%
Net margin: 3.432039432972342%
Asset turnover: 0.5737359929301503
Equity multiplier (leverage): 1.2936739272047848
EBIT margin: 7.7155157066287074%
Interest burden factor: 0.6393314059734122
Tax burden factor: 0.6957629052595113
ROE archetype: Low Return
DuPont ROE decomposition for CPHC (annual period ending 2025-12-31)
ROE: -0.6303998717079209%
Net margin: -0.8887904386253026%
Asset turnover: 0.5354296726768725
Equity multiplier (leverage): 1.3246901490403558
EBIT margin: 4.226906294757459%
Interest burden factor: -0.323460819598819
ROE archetype: Low Return
DuPont ROE decomposition for CPRX (quarterly period ending 2025-03-31)
ROE: 7.143171892134164%
Net margin: 40.119218503616864%
Asset turnover: 0.15560056861692295
Equity multiplier (leverage): 1.1442672196181964
EBIT margin: 44.80734827218023%
Interest burden factor: 1.1249704104660154
Tax burden factor: 0.7959066296327469
ROE archetype: Standard Business
DuPont ROE decomposition for CPRX (quarterly period ending 2025-06-30)
ROE: 6.3149347698311225%
Net margin: 35.553311545205815%
Asset turnover: 0.1558528424537175
Equity multiplier (leverage): 1.1396567917542764
EBIT margin: 45.235154848085806%
Interest burden factor: 1.045174816736553
Tax burden factor: 0.7519951510253561
ROE archetype: Standard Business
DuPont ROE decomposition for CPRX (quarterly period ending 2025-09-30)
ROE: 5.943121323761226%
Net margin: 35.569976818157315%
Asset turnover: 0.14666741124487712
Equity multiplier (leverage): 1.1391932091481485
EBIT margin: 44.65672003881611%
Interest burden factor: 1.071951348333258
Tax burden factor: 0.7430562398817484
ROE archetype: Standard Business
DuPont ROE decomposition for CPRX (quarterly period ending 2025-12-31)
ROE: 5.622580371541836%
Net margin: 34.530479054864266%
Asset turnover: 0.1415980192811126
Equity multiplier (leverage): 1.1499418782371742
EBIT margin: 40.52472594077831%
Interest burden factor: 1.162581250202115
Tax burden factor: 0.7329244377685985
ROE archetype: Standard Business
DuPont ROE decomposition for CPRX (quarterly period ending 2026-03-31)
ROE: 6.480440678913961%
Net margin: 42.66282883727157%
Asset turnover: 0.1326973972603348
Equity multiplier (leverage): 1.1447021172212013
EBIT margin: 49.02068411540264%
Interest burden factor: 1.150166593838759
Tax burden factor: 0.7566752543660734
ROE archetype: Standard Business
DuPont ROE decomposition for CQD.DE (annual period ending 2022-12-31)
ROE: 46.60929157701809%
Net margin: 10.827070452778498%
Asset turnover: 0.3737951744704995
Equity multiplier (leverage): 11.516694557335246
EBIT margin: 22.662989152567473%
Interest burden factor: 0.6094911377930246
Tax burden factor: 0.7838381131064058
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CQD.DE (annual period ending 2023-12-31)
ROE: 38.588770308431435%
Net margin: 9.634295969381215%
Asset turnover: 0.3743846755063144
Equity multiplier (leverage): 10.698500018337183
EBIT margin: 22.90182577325251%
Interest burden factor: 0.5480569326723173
Tax burden factor: 0.7675809746133645
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CQD.DE (annual period ending 2024-12-31)
ROE: 34.00435729847494%
Net margin: 10.625397113551784%
Asset turnover: 0.3706769219381386
Equity multiplier (leverage): 8.63363834422658
EBIT margin: 24.04465825542344%
Interest burden factor: 0.56640241600604
Tax burden factor: 0.7801919488136497
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CQD.DE (annual period ending 2025-12-31)
ROE: 28.66802565504897%
Net margin: 10.52689232117428%
Asset turnover: 0.36007928134028855
Equity multiplier (leverage): 7.563093521602943
EBIT margin: 24.325409865994814%
Interest burden factor: 0.5597418192734914
Tax burden factor: 0.7731295253419147
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CR1.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 3.5017209787307273
ROE archetype: Standard Business
DuPont ROE decomposition for CRAC (annual period ending 2025-12-31)
Equity multiplier (leverage): 1.0105837379358429
ROE archetype: Standard Business
DuPont ROE decomposition for CRAP.PA (annual period ending 2022-12-31)
ROE: 4.931223376845861%
Net margin: 32.21226755481543%
Asset turnover: 0.017069530969653208
Equity multiplier (leverage): 8.968334337189685
Tax burden factor: 0.8381632464411166
ROE archetype: Low Return
DuPont ROE decomposition for CRAP.PA (annual period ending 2023-12-31)
ROE: 3.8898232477178474%
Net margin: 27.142550681111228%
Asset turnover: 0.01676936794127135
Equity multiplier (leverage): 8.545992677191906
Tax burden factor: 0.854547189757444
ROE archetype: Low Return
DuPont ROE decomposition for CRAP.PA (annual period ending 2024-12-31)
ROE: 3.917460046007416%
Net margin: 29.59262360825403%
Asset turnover: 0.016608115572248405
Equity multiplier (leverage): 7.970778618462317
Tax burden factor: 0.866771078723239
ROE archetype: Low Return
DuPont ROE decomposition for CRAP.PA (annual period ending 2025-12-31)
ROE: 3.9017229373351046%
Net margin: 30.571411146323445%
Asset turnover: 0.01739170035668184
Equity multiplier (leverage): 7.338358029885421
Tax burden factor: 0.8353062433653443
ROE archetype: Low Return
DuPont ROE decomposition for CRCL.L (annual period ending 2022-06-30)
ROE: -68.1177976952625%
Asset turnover: 0
Equity multiplier (leverage): 1.5592189500640206
ROE archetype: Low Return
DuPont ROE decomposition for CRCL.L (annual period ending 2023-06-30)
ROE: -29.604581838571438%
Asset turnover: 0
Equity multiplier (leverage): 1.3518869759750998
ROE archetype: Low Return
DuPont ROE decomposition for CRCL.L (annual period ending 2024-06-30)
ROE: -53.240943776861684%
Asset turnover: 0
Equity multiplier (leverage): 1.6566967809841244
ROE archetype: Low Return
DuPont ROE decomposition for CRCL.L (annual period ending 2025-06-30)
ROE: -155.84079057958579%
Asset turnover: 0
Equity multiplier (leverage): 2.234617521063025
ROE archetype: Low Return
DuPont ROE decomposition for CRD.V (annual period ending 2022-12-31)
ROE: -2842.1921388695537%
Asset turnover: 0
Equity multiplier (leverage): 2.4390954159978406
ROE archetype: Low Return
DuPont ROE decomposition for CRD.V (annual period ending 2023-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CRD.V (annual period ending 2024-12-31)
ROE: 2972.4895693458384%
Asset turnover: 0
Equity multiplier (leverage): 2.311539721392441
Tax burden factor: 1
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CRD.V (annual period ending 2025-12-31)
ROE: 116.40871684721768%
Asset turnover: 0
Equity multiplier (leverage): 1.1187167284106754
Tax burden factor: 1
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CRDF (quarterly period ending 2025-03-31)
ROE: -18.95422992268187%
Net margin: -12324.770642201835%
Asset turnover: 0.0012852712629853667
Equity multiplier (leverage): 1.1965545459676055
EBIT margin: -13194.495412844037%
ROE archetype: Low Return
DuPont ROE decomposition for CRDF (quarterly period ending 2025-06-30)
ROE: -21.536584235646654%
Net margin: -11523.140495867769%
Asset turnover: 0.001507356147147858
Equity multiplier (leverage): 1.2399097944115784
EBIT margin: -12212.396694214876%
ROE archetype: Low Return
DuPont ROE decomposition for CRDF (quarterly period ending 2025-09-30)
ROE: -20.96539908376476%
Net margin: -9381.666666666666%
Asset turnover: 0.0017201958156236785
Equity multiplier (leverage): 1.2991079742262281
EBIT margin: -9978.333333333334%
ROE archetype: Low Return
DuPont ROE decomposition for CRDF (quarterly period ending 2025-12-31)
ROE: -15.324173373824035%
Net margin: -2969.5473251028807%
Asset turnover: 0.0038674560733384265
Equity multiplier (leverage): 1.3343243645012635
EBIT margin: -3220.9876543209875%
ROE archetype: Low Return
DuPont ROE decomposition for CRDF (quarterly period ending 2026-03-31)
ROE: -30.825124536499494%
Net margin: -30109.756097560978%
Asset turnover: 0.0007383662296499064
Equity multiplier (leverage): 1.3865188458993472
EBIT margin: -31341.46341463415%
ROE archetype: Low Return
DuPont ROE decomposition for CRESY (quarterly period ending 2024-12-31)
ROE: 3.3230193098761593%
Net margin: 21.569938643109378%
Asset turnover: 0.06465130813490468
Equity multiplier (leverage): 2.382904506119734
EBIT margin: 19.900906079767868%
Interest burden factor: 2.196816663391629
Tax burden factor: 0.4933808007442127
ROE archetype: Low Return
DuPont ROE decomposition for CRESY (quarterly period ending 2025-03-31)
ROE: 6.020914671546486%
Net margin: 45.27909751058904%
Asset turnover: 0.055231692709476594
Equity multiplier (leverage): 2.4075557743794436
EBIT margin: 24.86002518923098%
Interest burden factor: 3.3968699839486356
Tax burden factor: 0.5361882260287458
ROE archetype: Standard Business
DuPont ROE decomposition for CRESY (quarterly period ending 2025-09-30)
ROE: 4.360925775604349%
Net margin: 34.575501759651395%
Asset turnover: 0.054550501973058454
Equity multiplier (leverage): 2.312125759765587
EBIT margin: 19.122905606710848%
Interest burden factor: 3.13304439190964
Tax burden factor: 0.5770959966464054
ROE archetype: Low Return
DuPont ROE decomposition for CRESY (quarterly period ending 2025-12-31)
ROE: 2.8322950047412405%
Net margin: 24.43699370083349%
Asset turnover: 0.04896383553178562
Equity multiplier (leverage): 2.3670927705726865
EBIT margin: 23.00187641666206%
Interest burden factor: 1.0692341406172683
Tax burden factor: 0.9936002538742265
ROE archetype: Low Return
DuPont ROE decomposition for CRESY (quarterly period ending 2026-03-31)
ROE: 1.509095353129981%
Net margin: 15.904261002742523%
Asset turnover: 0.04012516607639879
Equity multiplier (leverage): 2.3647560465336626
EBIT margin: 18.14537352534954%
Interest burden factor: 0.3233953457939849
Tax burden factor: 2.710277852711087
ROE archetype: Low Return
DuPont ROE decomposition for CREX (annual period ending 2022-12-31)
ROE: 7.334141287775128%
Net margin: 4.327566320645905%
Asset turnover: 0.6566689388775279
Equity multiplier (leverage): 2.580828022987607
EBIT margin: -4.35524798154556%
Tax burden factor: 0.9595907928388747
ROE archetype: Standard Business
DuPont ROE decomposition for CREX (annual period ending 2023-12-31)
ROE: -10.795809593824664%
Net margin: -6.5026790063321975%
Asset turnover: 0.6603602549856716
Equity multiplier (leverage): 2.514096673405624
EBIT margin: 2.980117787716424%
Interest burden factor: -2.1203566121842496
ROE archetype: Low Return
DuPont ROE decomposition for CREX (annual period ending 2024-12-31)
ROE: -12.922952238860951%
Net margin: -6.898179100955677%
Asset turnover: 0.7479244339532455
Equity multiplier (leverage): 2.5047797977565343
EBIT margin: 1.8444960081802808%
Interest burden factor: -3.626865671641791
ROE archetype: Low Return
DuPont ROE decomposition for CREX (annual period ending 2025-12-31)
ROE: -22.17399458778769%
Net margin: -14.460441710930949%
Asset turnover: 0.5293132947976878
Equity multiplier (leverage): 2.897007207352035
EBIT margin: -5.51090299133352%
ROE archetype: Low Return
DuPont ROE decomposition for CRI.PA (annual period ending 2022-12-31)
ROE: 7.895677027509827%
Net margin: 3.0113094427033658%
Asset turnover: 0.829078174423859
Equity multiplier (leverage): 3.1625580564487326
EBIT margin: 6.608529772448563%
Interest burden factor: 0.4247422680412371
Tax burden factor: 1.0728155339805825
ROE archetype: Standard Business
DuPont ROE decomposition for CRI.PA (annual period ending 2023-12-31)
ROE: -0.2527124339894383%
Net margin: -0.1073125862333282%
Asset turnover: 0.7367574893901309
Equity multiplier (leverage): 3.1963283725396066
EBIT margin: 3.9552353211712394%
Interest burden factor: -0.49224806201550386
ROE archetype: Low Return
DuPont ROE decomposition for CRI.PA (annual period ending 2024-12-31)
ROE: 2.384148633410299%
Net margin: 1.7113783533765032%
Asset turnover: 0.43408279429923335
Equity multiplier (leverage): 3.2093325457767277
EBIT margin: 7.377428307123034%
Interest burden factor: -0.006269592476489028
ROE archetype: Low Return
DuPont ROE decomposition for CRI.PA (annual period ending 2025-12-31)
ROE: -9.147630608829607%
Net margin: -5.718370264474625%
Asset turnover: 0.4524683722348341
Equity multiplier (leverage): 3.5354778386340486
EBIT margin: 0.6433166547533953%
Interest burden factor: -9.88888888888889
ROE archetype: Low Return
DuPont ROE decomposition for CRLO.PA (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 5.4080608842698465
ROE archetype: Standard Business
DuPont ROE decomposition for CRLO.PA (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 5.234482934506167
ROE archetype: Standard Business
DuPont ROE decomposition for CROWN.NS (annual period ending 2023-03-31)
ROE: 18.440256691780565%
Net margin: 20.212578329252608%
Asset turnover: 0.4878108030142768
Equity multiplier (leverage): 1.8702248892590772
EBIT margin: 12.233888035855085%
Interest burden factor: 1.3011363636363638
Tax burden factor: 1.2697973017011015
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CROWN.NS (annual period ending 2024-03-31)
ROE: 19.14744546067908%
Net margin: 19.602002797083344%
Asset turnover: 0.37759851735045596
Equity multiplier (leverage): 2.586902818328748
EBIT margin: 29.33200952289445%
Interest burden factor: 0.8954564755838641
Tax burden factor: 0.7463012139605463
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CROWN.NS (annual period ending 2025-03-31)
ROE: 38.41058091508663%
Net margin: 54.17545562231515%
Asset turnover: 0.24101997611626352
Equity multiplier (leverage): 2.9416788894521515
EBIT margin: 46.93516390986028%
Interest burden factor: 1.5492687080001217
Tax burden factor: 0.7450363880449375
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CROWN.NS (annual period ending 2026-03-31)
ROE: 12.187350361775316%
Net margin: 22.334342923178014%
Asset turnover: 0.19268233818466646
Equity multiplier (leverage): 2.8320062570825297
EBIT margin: 41.212414178569%
Interest burden factor: 0.7290215771082277
Tax burden factor: 0.7433695060124859
ROE archetype: Standard Business
DuPont ROE decomposition for CRWD (quarterly period ending 2025-01-31)
ROE: -2.78048532096464%
Net margin: -8.71787314201285%
Asset turnover: 0.12164896987649826
Equity multiplier (leverage): 2.6218124767808293
EBIT margin: -8.058378631659894%
ROE archetype: Low Return
DuPont ROE decomposition for CRWD (quarterly period ending 2025-04-30)
ROE: -3.0621161947162165%
Net margin: -9.449047247048759%
Asset turnover: 0.12667177134119392
Equity multiplier (leverage): 2.5583137332815853
EBIT margin: -10.75850481315602%
ROE archetype: Low Return
DuPont ROE decomposition for CRWD (quarterly period ending 2025-07-31)
ROE: -2.1314340890826626%
Net margin: -6.642274447539334%
Asset turnover: 0.12981705316404302
Equity multiplier (leverage): 2.4718570131510953
EBIT margin: -9.664981966753126%
ROE archetype: Low Return
DuPont ROE decomposition for CRWD (quarterly period ending 2025-10-31)
ROE: -0.8655274680443938%
Net margin: -2.753750473974352%
Asset turnover: 0.12820513086854893
Equity multiplier (leverage): 2.451607062549308
EBIT margin: -5.626359131581761%
ROE archetype: Low Return
DuPont ROE decomposition for CRWD (quarterly period ending 2026-01-31)
ROE: 1.440781131653512%
Net margin: 4.708302212008044%
Asset turnover: 0.12401416281402967
Equity multiplier (leverage): 2.4675297381904637
EBIT margin: 1.0560949918605764%
Interest burden factor: 4.19556071376759
Tax burden factor: 1.062603734439834
ROE archetype: Low Return
DuPont ROE decomposition for CRWD (quarterly period ending 2026-04-30)
ROE: 1.0049478915300794%
Net margin: 3.317338190814424%
Asset turnover: 0.12395602158163714
Equity multiplier (leverage): 2.4439153876988877
EBIT margin: -2.2083833407066393%
Tax burden factor: 1.176714538053913
ROE archetype: Low Return
DuPont ROE decomposition for CSC.AX (annual period ending 2022-12-31)
ROE: 4.281294498870389%
Net margin: 9.892967105315748%
Asset turnover: 0.2557410385013087
Equity multiplier (leverage): 1.692186061255604
EBIT margin: 9.718636251661376%
Interest burden factor: 1.4484896066995663
Tax burden factor: 0.7027580902431848
ROE archetype: Low Return
DuPont ROE decomposition for CSC.AX (annual period ending 2023-12-31)
ROE: -3.3050883254615484%
Net margin: -7.1477531806418995%
Asset turnover: 0.256373663876583
Equity multiplier (leverage): 1.803599526608699
EBIT margin: 1.2686713539407481%
Interest burden factor: -5.042834977280283
ROE archetype: Low Return
DuPont ROE decomposition for CSC.AX (annual period ending 2024-12-31)
ROE: 2.531498484485615%
Net margin: 5.095844531464648%
Asset turnover: 0.2647892453486657
Equity multiplier (leverage): 1.87612236293336
EBIT margin: 8.797117454130932%
Interest burden factor: 0.8999440123577543
Tax burden factor: 0.6436655823226948
ROE archetype: Low Return
DuPont ROE decomposition for CSC.AX (annual period ending 2025-12-31)
ROE: 9.783805071207494%
Net margin: 14.72762807315133%
Asset turnover: 0.3572270379928195
Equity multiplier (leverage): 1.8596476289457653
EBIT margin: 20.308350027098854%
Interest burden factor: 1.0064966303784344
Tax burden factor: 0.7205196720939959
ROE archetype: Standard Business
DuPont ROE decomposition for CSMG3.SA (annual period ending 2022-12-31)
ROE: 11.625341132431478%
Net margin: 13.653582607977683%
Asset turnover: 0.4683122855745437
Equity multiplier (leverage): 1.818124136227458
EBIT margin: 19.81306020620526%
Interest burden factor: 0.8546604740550929
Tax burden factor: 0.8063088816525392
ROE archetype: Standard Business
DuPont ROE decomposition for CSMG3.SA (annual period ending 2023-12-31)
ROE: 19.37619011676493%
Net margin: 18.628787100174097%
Asset turnover: 0.5629568477729179
Equity multiplier (leverage): 1.8476031816553464
EBIT margin: 26.471483969148522%
Interest burden factor: 0.9113404817940776
Tax burden factor: 0.7721925888106627
ROE archetype: Balanced Compounder